von Schenck H, Falkensson M, Lundberg B
Clin Chem. 1986 Mar;32(3):526-9.
Hemoglobinometry according to the International Committee of Standardization in Hematology (ICSH) suffers from imprecision related to high sample dilution and from potential errors owing to sample turbidity. We have evaluated a new instrument, "HemoCue," that measures hemoglobin at two wavelengths as azide methemoglobin, without dilution. The HemoCue method is superior to the ICSH method: by correction for turbidity, it avoids false hemoglobin readings that may arise from hyperlipemia or some large M-component of the immunoglobulin M class. We find the equipment suitable for use in outpatient units.
根据国际血液学标准化委员会（ICSH）的血红蛋白测定法存在与高样本稀释相关的不精确性以及由于样本浑浊导致的潜在误差。我们评估了一种新仪器“HemoCue”，它通过测量叠氮高铁血红蛋白在两个波长下的吸光度来测定血红蛋白，无需稀释。HemoCue方法优于ICSH方法：通过对浑浊度进行校正，它避免了因高脂血症或某些免疫球蛋白M类的大分子M成分可能产生的血红蛋白错误读数。我们发现该设备适用于门诊单位。
